Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 85%
filed 2026-10-20
Item 7.01
The filing announces a webcast of a conference call to discuss third quarter 2026 operating results, with the earnings release to be issued on October 21, 2026. Although the Item 7.01 disclosure itself is technically an announcement of the webcast timing, the substance centers on the upcoming earnings release and analyst call covering Q3 2026 results. This is material to investors as it signals the imminent disclosure of quarterly financial performance.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-10-20
Item 8.01
ARMOUR announced a cash dividend of $0.24 per share payable to common stockholders for November 2026, with a record date of November 16, 2026 and payment date of November 27, 2026. This is a routine but material dividend declaration by a REIT, which is required to distribute substantially all ordinary taxable income to maintain tax status. Dividend distributions are material to investors assessing returns and capital allocation.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-10-20
EX-99.1
American Airlines exercised subscription warrants to acquire 31,838,775 common shares, resulting in a total capital increase of BRL 512,811,716.28 and bringing total outstanding shares to 400,829,250. This represents a material dilutive issuance of equity securities. While the warrants were previously issued (not a new private placement), the exercise event itself constitutes a material capital-raising transaction that dilutes existing shareholders and would affect investor assessment of ownership and voting power.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-10-20
Item 5.03
Moleculin Biotech effected a 1-for-20 reverse stock split of its common stock, effective October 20, 2026, pursuant to stockholder approval and board authorization. The reverse split consolidated approximately 20.9 million outstanding shares into approximately 1.05 million shares, materially modifying the rights and economic interests of security holders by altering per-share economics, voting power, and the company's market capitalization presentation.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-10-20
Item 8.01
The Fifth Circuit vacated the class certification order in a securities class action against Filana and its officers, a material development in ongoing litigation. The court accepted the Company's position on market efficiency and meme-stock dynamics, significantly narrowing the scope of the class and reducing litigation risk. This favorable appellate ruling on class certification is a material event affecting the registrant's legal exposure and financial contingencies.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-10-20
Item 2.02
Mercantile Bank Corporation issued a press release on October 20, 2026, announcing third-quarter 2026 earnings of $24.1 million ($1.39 per diluted share), along with detailed operating results, balance sheet metrics, and management commentary on financial performance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-10-20
Item 1.01
Dorchester Minerals entered into a Contribution and Exchange Agreement on October 16, 2026, to acquire approximately 4,300 net royalty acres of mineral and royalty interests in the Williston Basin in exchange for 1,250,000 common units, with expected closing on October 30, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 72%
filed 2026-10-20
Item 1.01
The filing discloses entry into a material definitive agreement (Item 1.01) involving a loan extension that modifies a direct financial obligation. The Extension Agreement extends the maturity of a $4.95 million loan to October 10, 2031, resets the interest rate to 7.28% per annum, and requires a principal paydown of $431,411.38. While this is technically a modification of existing debt rather than issuance of new debt, the extension and restructuring of a material obligation constitutes a material change to the registrant's financial obligations and is disclosed under Item 1.01, warranting classification as a debt-related event. The materiality is evident from the loan size and the five-year extension of maturity.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-10-20
Item 4.01
The filing discloses the dismissal of BDO USA, P.C. as the Company's independent registered public accounting firm effective October 15, 2026, and the engagement of CBIZ CPAs P.C. as the new auditor. This is a classic auditor change under Item 4.01. While the disclosure notes BDO's prior report contained an explanatory paragraph regarding substantial doubt about going concern, the principal event disclosed is the change in auditors itself, making auditor_change the appropriate classification.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-20
Item 2.02
General Motors disclosed its 2026 third-quarter consolidated earnings on October 20, 2026, reporting Q3 revenue of $50.0 billion, net income of $3.3 billion, and EBIT-adjusted of $4.1 billion. The filing includes a comprehensive news release with financial statements, updated full-year 2026 guidance (narrowing EBIT-adjusted to $14.5–$15.5 billion), and segment results. This is a standard quarterly earnings release with material financial results and forward guidance that would affect investor assessment of the registrant's financial performance.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 92%
filed 2026-10-20
EX-99.1
VEON announced the cancellation of approximately 1.5% of its total issued shares (26,951,230 common shares / 1,078,049 ADSs) as part of an ongoing share buyback program announced September 23, 2026 to repurchase and cancel 3.9% of outstanding shares. Share repurchase programs and cancellations constitute a return of capital to shareholders and fall within the dividend_distribution category, which explicitly includes "share-repurchase programs." This is material as it affects share count and per-share metrics.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-10-20
Item 5.07
Shareholders of Healthcare AI Acquisition Corp. voted on October 13, 2026 to approve an Extension Proposal extending the business combination deadline from October 14, 2026 to October 14, 2027. The proposal passed with 5,390,600 votes in favor, 0 against, and 0 abstentions.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-10-20
The filing discloses a multi-phase workforce reduction and organizational restructuring following the June 30, 2026 Cataneo acquisition, with one-time exit costs of approximately $177,000 and expected total annualized cost reductions of $1.919 million across three phases. While this involves severance and exit costs typical of workforce reductions, the disclosure emphasizes integration synergies and operational restructuring rather than a standalone layoff announcement, making it primarily an operational/integration event rather than a discrete workforce_reduction event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
The filing discloses the appointment of Timothy A. Peterman as permanent Chief Financial Officer and Secretary of Laser Photonics Corporation, effective October 6, 2026, following his service as Acting CFO since September 8, 2026. Item 5.02 details his employment agreement with specific compensation terms ($300,000 base salary, equity awards, bonus structure, and severance provisions). While the filing also includes compensatory arrangement details, the principal disclosed action is Peterman's appointment to a permanent executive officer role, making exec_appointment the most salient classification.
View raw filing on EDGAR →
6-K
Periodic Interim
confidence 95%
filed 2026-10-20
This 6-K filing contains unaudited interim condensed consolidated financial statements for the six-month period ended June 30, 2026, including a Statement of Operations, Management's Discussion and Analysis, and detailed financial disclosures. The document explicitly presents comparative financial data for H1 2025 and H1 2026, with revenue of SGD 20.8 million and net income of SGD 1.7 million for the interim period. This is a periodic interim financial report, not a discrete event or earnings press release.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-10-20
Item 3.03
The filing discloses a 1-for-150 reverse stock split effected on October 20, 2026, pursuant to board and shareholder approval. This is a material modification to the rights of security holders under Item 3.03, reducing outstanding shares from ~543.9 million to ~3.6 million. While reverse splits are governance-related capital structure events, they do not fit the specific named categories (exec appointment/departure, compensation, M&A, etc.). The event is material to investors as it affects share structure, trading price, and the company's stated goal of Nasdaq uplisting, making governance_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
The filing discloses that Dan Golding was elected to Soluna's Board of Directors at the October 16, 2026 annual meeting of stockholders. The press release emphasizes his appointment as a board member, his 30+ years of data center experience including leadership at Google and Iron Mountain, and his prior service as an advisor since 2023. This is a clear executive appointment event material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 92%
filed 2026-10-20
The filing discloses a cost reduction plan targeting $3 million in annualized savings, explicitly including "workforce reductions, infrastructure consolidation and elimination of legacy overhead costs" with approximately $270,000 in one-time transition expenses. This is a material operational restructuring that would affect investor assessment of the company's financial trajectory and operational efficiency.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 94%
filed 2026-10-20
Item 8.01
DataMeds AI announced on October 20, 2026 that it has regained compliance with Nasdaq Listing Rule 5550(b)(1) after receiving a delisting notice on April 13, 2026 for failure to maintain the required minimum stockholders' equity of $2.5 million. The company has remediated the deficiency as of October 19, 2026, but faces continued delisting risk if it fails to evidence compliance upon filing its next periodic report.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-10-20
The 6-K discloses results of an Extraordinary General Meeting of Shareholders held on October 15, 2026, where shareholders voted on three proposals: (1) increase of authorized share capital from US$100,000 to US$10,000,000 (a 100x increase), (2) adoption of Third Amended and Restated Memorandum and Articles of Association, and (3) adjournment authority. All three proposals were approved with voting tallies provided for each. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the capital increase is material to investors' assessment of the company's capitalization structure.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-10-20
EX-99.1
Dogness received a Nasdaq deficiency notification on October 19, 2026, for failure to maintain the minimum bid price requirement (closing bid below $1.00 for 30 consecutive business days). The company has 180 calendar days until April 19, 2027, to regain compliance or faces potential delisting. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially affecting the registrant's continued listing status and investor assessment.
View raw filing on EDGAR →
8-K
Legal Other
confidence 85%
filed 2026-10-20
Item 8.01
Onity filed a declaratory judgment action in federal court seeking judicial clarification of how a New York mortgage servicing regulation applies to optional expedited payment fees. The Company is also engaged in ongoing regulatory discussions with New York regulators concerning fee practices, representing material legal and regulatory risk to the mortgage servicing business.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-20
The filing discloses a private placement financing completed on October 15, 2026, in which PURE Bioscience issued 10,183,486 shares of common stock at $0.0545 per share to accredited investors, raising $555,000. The shares were issued pursuant to a Securities Purchase Agreement under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D—a classic unregistered equity issuance. Item 3.02 explicitly incorporates the private placement details, confirming this is an unregistered sale of equity securities. The substantial share count and dilutive nature of the issuance make this material to investors assessing the registrant's capital structure and ownership.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-10-20
Item 5.02
The filing discloses a new executive employment agreement for Andrew M. Johnson (EVP, CFO, and Chief Legal Officer) entered into on October 14, 2026. The agreement specifies compensatory arrangements including a minimum annual base salary of $250,000, eligibility for annual performance bonuses, restricted stock unit awards under the 2024 Incentive Award Plan, and severance benefits upon termination without Cause or for Good Reason (12 months base salary continuation, bonus, COBRA coverage, and accelerated RSU vesting). While the agreement also supersedes a prior agreement, the central disclosure focuses on the compensation terms and severance arrangements rather than a departure or new appointment, making this an executive compensation event material to investors assessing executive cost structure and incentive alignment.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-20
The filing discloses completion of a private placement of 20,338,974 shares of common stock for approximately $24.0 million in gross proceeds. This is an unregistered equity issuance that materially dilutes existing shareholders and represents a significant capital raise for the company, meeting the definition of dilutive_issuance.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-10-20
The filing discloses that SHF Holdings received notice from Nasdaq on October 20, 2026 that it has an additional 180-day compliance period (until April 19, 2027) to regain compliance with the minimum $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2). This follows an initial 180-day period that expired October 19, 2026. Item 3.01 explicitly states that if the company does not regain compliance by April 19, 2027, "the Staff will provide written notification to the Company that its securities will be subject to delisting." This is a clear delisting risk disclosure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-10-20
Host Digital's Board authorized a $15 million share repurchase program on October 19, 2026, disclosed in Items 7.01 and 8.01. Share repurchases constitute a return of capital to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The authorization is material to investors as it signals management's confidence in valuation and affects capital allocation strategy.
View raw filing on EDGAR →
6-K
Other material
confidence 65%
filed 2026-10-20
EX-99.1
The Company discloses "unusual trading activity" in its ordinary shares on October 19, 2026, and states it has been unable to determine whether corrective actions are appropriate or identify any material business development or other reason to account for the unusual market action. This disclosure is made pursuant to NYSE American Company Guide Section 401(d), suggesting a regulatory obligation to address unexplained trading anomalies. While the Company explicitly denies knowledge of any underlying material event, the unusual trading activity itself—and the Company's inability to explain it—could signal market concern about undisclosed information or operational issues, making it material to investor assessment. The event does not fit neatly into any specific category (not a delisting risk, not a cybersecurity incident, not litigation) but is clearly material and warrants disclosure.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-10-20
The 6-K discloses the results of a shareholder vote on a 1-for-10 share consolidation. The filing states that on October 16, 2026, shareholders representing a majority of votes passed written resolutions approving the Share Consolidation without holding a meeting. This is a material capital structure change requiring shareholder approval and disclosure of voting results, fitting the shareholder_vote_results category.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-10-20
Item 7.01
NexMetals disclosed an updated Mineral Resource Estimate for Selebi North showing nearly tripled Indicated Mineral Resources (3.00 Mt to 8.95 Mt) and increased Inferred Mineral Resources (5.83 Mt to 9.48 Mt), along with new geological findings suggesting potential deposit connectivity and an intrusive keel. This is a material operational/technical disclosure about the company's core mining asset that would affect investor assessment of project scale and economics, though it does not fit the specific categories of earnings release, M&A activity, or other defined event types. The disclosure is furnished under Item 7.01 (Regulation FD Disclosure) and represents a significant update to the company's mineral resource base.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-10-20
The filing discloses entry into a Securities Purchase Agreement on October 13, 2026, under which Netcapital issued a convertible promissory note to Hinterland Partners LLC with principal amount of $641,936.66 (funded in tranches). This is a creation of a direct financial obligation under Item 2.03. While the note is convertible into common stock and includes warrant issuances, the primary event is the debt issuance itself. The filing also references Item 3.02 (unregistered equity sales), but the central transaction is the debt instrument with conversion features rather than a pure equity issuance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-10-20
The filing discloses the mutual separation of three named executive officers—Kyle Wood (Chief Legal Officer and Secretary), Megan Pacchia (Chief Operating Officer), and Renae Cormier (Chief Financial Officer)—effective October 21, 2026. While the filing also includes appointments of interim and permanent replacements (Catalina Abbey as interim CFO and Caroline Hennigar as COO), the primary and most salient event is the departure of three senior officers with severance packages totaling $1.5 million in cash plus equity awards. This is material to investors as it signals significant leadership turnover at a recently public company.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-10-20
The filing discloses a Staff Determination from Nasdaq on October 14, 2026, notifying the Company that it has failed to regain compliance with Nasdaq Listing Rule 5250(c)(1) due to non-filing of its Q2 2026 Form 10-Q. The Staff Determination explicitly states that trading will be suspended on October 23, 2026, and Nasdaq will file a Form 25-NSE to remove the Company's securities from listing unless the Company requests a hearing. This is a textbook delisting-risk disclosure under Item 3.01, with the Company facing imminent suspension and delisting absent successful appeal to the Nasdaq Hearings Panel.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-10-20
Clean Energy Technologies issued a $500,000 convertible promissory note to Falcon Venture Limited on October 18, 2026, with conversion rights into common stock at 85% of the lowest traded price during the ten trading days prior to conversion. The filing explicitly discloses this under Item 3.02 (Unregistered Sales of Equity Securities) and Item 1.01 (Material Definitive Agreement), indicating a dilutive equity issuance. The conversion feature and the specific cap on conversion shares (2,432,004 shares) underscore the dilutive nature of this transaction, which is material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 25%
filed 2026-10-20
EX-99.1
This is a proxy statement and notice of annual general meeting, not a disclosure of vote results. The document solicits shareholder votes on multiple proposals including auditor reappointment, director reappointment, and complex share capital restructuring (increase, consolidations, reduction, reorganization). While the document references that the Board "unanimously recommends" approval, it does not disclose actual voting results from a completed meeting. The meeting is scheduled for November 6, 2026, which is after the filing date of October 20, 2026. This is a pre-meeting notice and proxy solicitation, not a post-meeting results disclosure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
The Board of Directors elected C. Michael Petters, the former President and CEO, to the Board of Directors effective October 19, 2026, and appointed him to the Cybersecurity and Finance Committees. While the disclosure also includes compensatory arrangements (annual cash retainer of $130,000, committee retainers of $20,000 each, and annual equity grant of $195,000 in deferred stock units), the principal disclosed action is Petters taking a board role. This is material as it involves a former chief executive rejoining the board of a major defense contractor.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-10-20
Item 1.01
ESG Inc. entered into a Control Share Purchase and Transfer Agreement on October 15, 2026, whereby DCG agreed to sell 9,641,110 shares (approximately 61.836% of outstanding common stock) to BevPoint Capital LP for $250,000, constituting a material change of control transaction with replacement of the incumbent board and officers upon closing.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-10-20
Item 5.02
The Board approved one-time restricted stock awards to CEO Zhi Yang ($118,000 / 62,461 shares) and CFO Edward F. Gobora ($30,000 / 15,880 shares), effective October 15, 2026.
View raw filing on EDGAR →
6-K
M&A activity
confidence 85%
filed 2026-10-20
Cosan discloses the termination of exclusive negotiations for a potential sale of its equity interest in Rumo S.A. The filing explicitly references prior notices (June 29, 2026) and a Material Fact disclosure (August 20, 2026) regarding proposals for the sale, and now reports that the exclusivity period has expired without reaching an agreement. This represents a material development in M&A activity—specifically the failure to complete a contemplated disposition of a significant asset—that would affect a reasonable investor's assessment of the company's capital structure and strategic direction.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-10-20
Item 8.01
News Corporation disclosed daily buy-back notifications under its $1 billion repurchase program authorized July 15, 2025, with approximately $542.9 million already deployed as of October 20, 2026. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The filing reports specific transactions (13.4M Class A shares and 54.6K Class B shares purchased on October 20, 2026) with total consideration of approximately $356.6 million, making this a material capital allocation event.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-20
Item 1.01
Nu-Med Plus entered into Subscription Agreements with accredited investors to sell 171,232 shares of Series A Preferred Stock for $450,000, and issued 50,000 shares of Series A Preferred Stock to a consultant, pursuant to Section 4(a)(2) and Regulation D exemptions. Upon full conversion, these securities would result in the issuance of approximately 4.4 million shares of common stock, materially diluting existing shareholders.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 94%
filed 2026-10-20
Item 3.01
Hilton announced its voluntary withdrawal from NYSE listing and transfer to Nasdaq, with trading ending on NYSE at market close November 4, 2026, and commencing on Nasdaq November 5, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-10-20
Item 2.02
Synchrony Financial issued a press release on October 20, 2026 disclosing third quarter 2026 earnings of $892 million, or $2.68 per diluted share, compared to $1.1 billion, or $2.86 per diluted share in Q3 2025. The filing explicitly states under Item 2.02 that the Company "issued a press release setting forth the Company's third quarter 2026 earnings" with the press release furnished as Exhibit 99.1. This is a standard quarterly earnings release disclosure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-10-20
Item 8.01
Weatherford announced redemption of $236 million in 8.625% Senior Notes due 2030 at par plus accrued interest, funded from cash on hand. While technically a debt retirement rather than issuance, this represents a material modification of the company's direct financial obligations and capital structure. The redemption of a substantial debt instrument is a significant financial event affecting the registrant's leverage and liquidity profile.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-20
Item 2.02
Weatherford issued a news release on October 20, 2026, announcing third quarter 2026 financial results, including revenue of $1,143 million, operating income of $153 million, net income of $120 million, and adjusted EBITDA of $254 million. The release is furnished as Exhibit 99.1 and incorporated into Item 2.02, which is the standard disclosure vehicle for quarterly earnings announcements. The filing includes detailed segment results, operational highlights, and forward guidance, all hallmarks of an earnings release.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
Suja Life appointed two independent directors, Robert B. Engel (former CoBank CEO with 45+ years in banking and accounting) and Zahir Ibrahim (former CFO of Annie's, KIND, and BARK with ~30 years in financial leadership), to its Board of Directors effective October 16, 2026. Engel was also appointed to the Audit Committee, and the Board size increased from seven to nine members.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-10-20
Item 1.01
Mount Logan Capital Inc.'s subsidiary MLM entered into a definitive Asset Purchase Agreement to acquire the investment adviser business of Alternative Fund Advisors, LLC for the AFA Asset Based Lending Fund, including goodwill, intellectual property, and books and records. The transaction, valued at up to $4.6 million in cash and deferred payments plus earnout fees, is expected to close in Q1 2027 subject to regulatory and shareholder approvals, and will expand Mount Logan's interval fund AUM to approximately $460 million and be immediately accretive to FRE.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-10-20
Item 2.03
AlTi Global entered into an $85.0 million senior secured credit facility on October 19, 2026, consisting of $60.0 million in term loan commitments and a $25.0 million revolving credit facility with a six-year maturity, secured by substantially all assets of the credit parties.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-10-20
Item 7.01
Hines Global Income Trust sourced two multifamily properties (Gables Station and Left Bank) that were placed into a $591 million Delaware Statutory Trust offering completed by Hines Private Wealth Solutions. This represents a significant capital deployment and strategic business activity—the largest DST offering to date—but is disclosed under Item 7.01 (Regulation FD Disclosure) rather than a dedicated M&A or capital-raising item. The event is material to investors as it demonstrates the company's asset sourcing capability and capital deployment strategy, but does not fit neatly into acquisition, debt issuance, or other specific financial categories; it is best classified as an operational/strategic business milestone.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-20
Item 5.02
Brett L.A. Manning was appointed Chief Business Officer of the Federal Home Loan Bank of Des Moines effective October 16, 2026, with responsibility for member-facing departments. While the disclosure includes compensatory details (base salary of $425,000 and incentive awards up to 80% of base), the principal disclosed action is the appointment of an executive officer to a new role, making exec_appointment the most salient classification. The appointment is material as it represents a significant leadership change in a key executive position.
View raw filing on EDGAR →